{
    "medicine_id": "ca0953fcfd7e9d2f3753abf9cadeb1412a18559a",
    "platform_id": "DB00421",
    "metadata": {
        "name": "011054 Niacinamide 4 Spironolactone 5 25 mg Tablet",
        "composition": "25 mg Spironolactone",
        "clinical_particulars": {
            "therapeutic_indications": "Spironolactone is indicated for the treatment of New York Heart Association Class III IV heart failure management of edema in cirrhotic adults not responsive to fluid and sodium restrictions primary hyperaldosteronism short term preoperatively primary hyperaldosteronism long term in patients with aldosterone producing adrenal adenomas that are not candidates for surgery or patients with bilarteral micro macronodular adrenal hyperplasia as an add on therapy in hypertension and in nephrotic syndrome when treatment of the disease as well as fluid and sodium restriction with other diuretics is inadequate Label Spironolactone has antiandrogenic activity which leads to many of its off label uses Spironolactone is used off label in the treatment of hirsutism female pattern hair loss and adult acne vulgaris A178135 Spironolactone is also frequently used for its antiandrogenic effects in transgender female patients due to its low cost and reducing male pattern hair growth A178138",
            "contraindications": {
                "disease": "Patients experiencing an overdose may present with drowsiness mental confusion maculopapular or erythematous rash nausea vomiting dizziness or diarrhea Vomiting is generally induced or a gastric lavage is performed Label Supportive treatment involves maintining hydration electrolyte balance and vital functions Label The oral LD50 in mice rats and rabbits is 1g kg Label Spironolactone should be avoided in pregnancy due to reports of feminization of male fetuses in animal studies Label Active metabolites of spironolactone are present in breast milk and levels that are likely inconsequential though the long term effects have not been studied Label In animal studies spironolactone slowed follicle development ovulation and implantation Label Spironolactone increased the incidence of benign adenomas in the testes of male rats benign uterine endometrial stromal polyps in female rats and thyroid follicular cell adenomas in both sexes of rats Label Spironolactone and canrenone are generally not considered to be mutagenic in tests but canrenone occasionally tests positive for mutagenicity with metabolic activation and spironolactone has occasionally tested inconclusive though slightly positive for mutagenicity Label",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Originally spironolactone was only studied for its potassium sparing diuretic effect A11837 Spironolactone competitively inhibits mineralocorticoid receptors in the distal convoluted tubule to promote sodium and water excretion and potassium retention A11837 Inhibition of this receptor leads to increased renin and aldosterone levels A11837 Spironolactone is structurally similar to progesterone and as a result is associated with progestogenic and antiandrogenic effects A11837",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00476",
                        "description": "The risk or severity of orthostatic hypotension and syncope can be increased when Spironolactone is combined with Duloxetine"
                    },
                    {
                        "drugbank-id": "DB01235",
                        "description": "The risk or severity of hypotension and orthostatic hypotension can be increased when Spironolactone is combined with Levodopa"
                    },
                    {
                        "drugbank-id": "DB00734",
                        "description": "Spironolactone may increase the hypotensive activities of Risperidone"
                    },
                    {
                        "drugbank-id": "DB00197",
                        "description": "Troglitazone may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00199",
                        "description": "Erythromycin may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00206",
                        "description": "Reserpine may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00396",
                        "description": "Progesterone may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "Chlorpromazine may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "Cimetidine may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00559",
                        "description": "Bosentan may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "Tamoxifen may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00932",
                        "description": "Tipranavir may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "Ethinylestradiol may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01016",
                        "description": "Glyburide may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01026",
                        "description": "Ketoconazole may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01586",
                        "description": "Ursodeoxycholic acid may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02659",
                        "description": "Cholic Acid may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "Fusidic acid may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB06290",
                        "description": "Simeprevir may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09078",
                        "description": "Lenvatinib may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12070",
                        "description": "Letermovir may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14057",
                        "description": "Valinomycin may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "Quinidine may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01045",
                        "description": "Rifampicin may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15822",
                        "description": "Pralsetinib may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00211",
                        "description": "The therapeutic efficacy of Midodrine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00217",
                        "description": "The therapeutic efficacy of Bethanidine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00221",
                        "description": "The therapeutic efficacy of Isoetharine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00292",
                        "description": "The therapeutic efficacy of Etomidate can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00368",
                        "description": "The therapeutic efficacy of Norepinephrine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00388",
                        "description": "The therapeutic efficacy of Phenylephrine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00397",
                        "description": "The therapeutic efficacy of Phenylpropanolamine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The therapeutic efficacy of Clonidine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00610",
                        "description": "The therapeutic efficacy of Metaraminol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00629",
                        "description": "The therapeutic efficacy of Guanabenz can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00633",
                        "description": "The therapeutic efficacy of Dexmedetomidine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00668",
                        "description": "The therapeutic efficacy of Epinephrine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00697",
                        "description": "The therapeutic efficacy of Tizanidine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00723",
                        "description": "The therapeutic efficacy of Methoxamine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00816",
                        "description": "The therapeutic efficacy of Orciprenaline can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00841",
                        "description": "The therapeutic efficacy of Dobutamine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00852",
                        "description": "The therapeutic efficacy of Pseudoephedrine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00865",
                        "description": "The therapeutic efficacy of Benzphetamine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00867",
                        "description": "The therapeutic efficacy of Ritodrine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00871",
                        "description": "The therapeutic efficacy of Terbutaline can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00901",
                        "description": "The therapeutic efficacy of Bitolterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00935",
                        "description": "The therapeutic efficacy of Oxymetazoline can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The therapeutic efficacy of Salmeterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "The therapeutic efficacy of Methyldopa can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00983",
                        "description": "The therapeutic efficacy of Formoterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01001",
                        "description": "The therapeutic efficacy of Salbutamol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01018",
                        "description": "The therapeutic efficacy of Guanfacine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01064",
                        "description": "The therapeutic efficacy of Isoprenaline can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01102",
                        "description": "The therapeutic efficacy of Arbutamine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The therapeutic efficacy of Pergolide can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The therapeutic efficacy of Bromocriptine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The therapeutic efficacy of Ergometrine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01274",
                        "description": "The therapeutic efficacy of Arformoterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01288",
                        "description": "The therapeutic efficacy of Fenoterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01291",
                        "description": "The therapeutic efficacy of Pirbuterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01363",
                        "description": "The therapeutic efficacy of Ephedra sinica root can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01364",
                        "description": "The therapeutic efficacy of Ephedrine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01365",
                        "description": "The therapeutic efficacy of Mephentermine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01366",
                        "description": "The therapeutic efficacy of Procaterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01407",
                        "description": "The therapeutic efficacy of Clenbuterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01408",
                        "description": "The therapeutic efficacy of Bambuterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01472",
                        "description": "The therapeutic efficacy of 4 Methoxyamphetamine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01537",
                        "description": "The therapeutic efficacy of 4 Bromo 2 5 dimethoxyphenethylamine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01577",
                        "description": "The therapeutic efficacy of Metamfetamine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01579",
                        "description": "The therapeutic efficacy of Phendimetrazine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB04846",
                        "description": "The therapeutic efficacy of Celiprolol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB04861",
                        "description": "The therapeutic efficacy of Nebivolol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB04948",
                        "description": "The therapeutic efficacy of Lofexidine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB05039",
                        "description": "The therapeutic efficacy of Indacaterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB05395",
                        "description": "The therapeutic efficacy of Amibegron can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06152",
                        "description": "The therapeutic efficacy of Nylidrin can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06190",
                        "description": "The therapeutic efficacy of Solabegron can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06262",
                        "description": "The therapeutic efficacy of Droxidopa can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06694",
                        "description": "The therapeutic efficacy of Xylometazoline can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06706",
                        "description": "The therapeutic efficacy of Isometheptene can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06707",
                        "description": "The therapeutic efficacy of Levonordefrin can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06711",
                        "description": "The therapeutic efficacy of Naphazoline can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06764",
                        "description": "The therapeutic efficacy of Tetryzoline can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06814",
                        "description": "The therapeutic efficacy of Protokylol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08893",
                        "description": "The therapeutic efficacy of Mirabegron can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08925",
                        "description": "The therapeutic efficacy of Adrafinil can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08941",
                        "description": "The therapeutic efficacy of Isoxsuprine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08957",
                        "description": "The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08985",
                        "description": "The therapeutic efficacy of Etilefrine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09080",
                        "description": "The therapeutic efficacy of Olodaterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "The therapeutic efficacy of Vilanterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09202",
                        "description": "The therapeutic efficacy of Cirazoline can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09203",
                        "description": "The therapeutic efficacy of Synephrine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09242",
                        "description": "The therapeutic efficacy of Moxonidine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The therapeutic efficacy of Doxofylline can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11124",
                        "description": "The therapeutic efficacy of Racepinephrine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11278",
                        "description": "The therapeutic efficacy of DL Methylephedrine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11373",
                        "description": "The therapeutic efficacy of Amitraz can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11428",
                        "description": "The therapeutic efficacy of Medetomidine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11477",
                        "description": "The therapeutic efficacy of Xylazine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11541",
                        "description": "The therapeutic efficacy of Ractopamine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11543",
                        "description": "The therapeutic efficacy of Romifidine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11556",
                        "description": "The therapeutic efficacy of Detomidine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11587",
                        "description": "The therapeutic efficacy of Etafedrine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11738",
                        "description": "The therapeutic efficacy of Rilmenidine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11785",
                        "description": "The therapeutic efficacy of Anisodamine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11871",
                        "description": "The therapeutic efficacy of PF 00610355 can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12080",
                        "description": "The therapeutic efficacy of Ritobegron can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12100",
                        "description": "The therapeutic efficacy of Abediterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12248",
                        "description": "The therapeutic efficacy of Tulobuterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12313",
                        "description": "The therapeutic efficacy of Dopexamine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12526",
                        "description": "The therapeutic efficacy of Batefenterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12779",
                        "description": "The therapeutic efficacy of Higenamine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12846",
                        "description": "The therapeutic efficacy of Reproterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13139",
                        "description": "The therapeutic efficacy of Levosalbutamol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13251",
                        "description": "The therapeutic efficacy of Octopamine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13378",
                        "description": "The therapeutic efficacy of Norfenefrine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13398",
                        "description": "The therapeutic efficacy of Oxyfedrine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13559",
                        "description": "The therapeutic efficacy of Rimiterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13624",
                        "description": "The therapeutic efficacy of Methoxyphenamine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13692",
                        "description": "The therapeutic efficacy of Tretoquinol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13777",
                        "description": "The therapeutic efficacy of Prenalterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13781",
                        "description": "The therapeutic efficacy of Xamoterol can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB14752",
                        "description": "The therapeutic efficacy of Racephedrine can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB14547",
                        "description": "The therapeutic efficacy of Chloride ion can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00648",
                        "description": "The therapeutic efficacy of Mitotane can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00698",
                        "description": "Nitrofurantoin may increase the hyperkalemic activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "Spironolactone may increase the arrhythmogenic activities of Ciprofloxacin"
                    },
                    {
                        "drugbank-id": "DB00416",
                        "description": "Spironolactone may increase the neuromuscular blocking activities of Metocurine iodide"
                    },
                    {
                        "drugbank-id": "DB00483",
                        "description": "Spironolactone may increase the neuromuscular blocking activities of Gallamine triethiodide"
                    },
                    {
                        "drugbank-id": "DB00565",
                        "description": "Spironolactone may increase the neuromuscular blocking activities of Cisatracurium"
                    },
                    {
                        "drugbank-id": "DB00728",
                        "description": "Spironolactone may increase the neuromuscular blocking activities of Rocuronium"
                    },
                    {
                        "drugbank-id": "DB00732",
                        "description": "Spironolactone may increase the neuromuscular blocking activities of Atracurium besylate"
                    },
                    {
                        "drugbank-id": "DB01135",
                        "description": "Spironolactone may increase the neuromuscular blocking activities of Doxacurium"
                    },
                    {
                        "drugbank-id": "DB01199",
                        "description": "Spironolactone may increase the neuromuscular blocking activities of Tubocurarine"
                    },
                    {
                        "drugbank-id": "DB01226",
                        "description": "Spironolactone may increase the neuromuscular blocking activities of Mivacurium"
                    },
                    {
                        "drugbank-id": "DB01336",
                        "description": "Spironolactone may increase the neuromuscular blocking activities of Metocurine"
                    },
                    {
                        "drugbank-id": "DB01337",
                        "description": "Spironolactone may increase the neuromuscular blocking activities of Pancuronium"
                    },
                    {
                        "drugbank-id": "DB01338",
                        "description": "Spironolactone may increase the neuromuscular blocking activities of Pipecuronium"
                    },
                    {
                        "drugbank-id": "DB01339",
                        "description": "Spironolactone may increase the neuromuscular blocking activities of Vecuronium"
                    },
                    {
                        "drugbank-id": "DB04834",
                        "description": "Spironolactone may increase the neuromuscular blocking activities of Rapacuronium"
                    },
                    {
                        "drugbank-id": "DB13295",
                        "description": "Spironolactone may increase the neuromuscular blocking activities of Atracurium"
                    },
                    {
                        "drugbank-id": "DB13584",
                        "description": "Spironolactone may increase the neuromuscular blocking activities of Gallamine"
                    },
                    {
                        "drugbank-id": "DB13648",
                        "description": "Spironolactone may increase the neuromuscular blocking activities of Alcuronium"
                    },
                    {
                        "drugbank-id": "DB01432",
                        "description": "The risk or severity of hyperkalemia and metabolic acidosis can be increased when Cholestyramine is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB05812",
                        "description": "The therapeutic efficacy of Abiraterone can be decreased when used in combination with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "Aripiprazole may increase the hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "Aripiprazole lauroxil may increase the hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09220",
                        "description": "Nicorandil may increase the hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "Spironolactone may decrease the excretion rate of Acetyldigitoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "Spironolactone may decrease the excretion rate of Deslanoside which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01092",
                        "description": "Spironolactone may decrease the excretion rate of Ouabain which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12843",
                        "description": "Spironolactone may decrease the excretion rate of Oleandrin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "Spironolactone may decrease the excretion rate of Cymarin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13307",
                        "description": "Spironolactone may decrease the excretion rate of Proscillaridin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13467",
                        "description": "Spironolactone may decrease the excretion rate of Lanatoside C which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13537",
                        "description": "Spironolactone may decrease the excretion rate of Gitoformate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13756",
                        "description": "Spironolactone may decrease the excretion rate of Peruvoside which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "Spironolactone may decrease the excretion rate of Digitoxin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB00159",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Icosapent is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00244",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Mesalazine is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00461",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Nabumetone is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00465",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Ketorolac is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00469",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Tenoxicam is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00482",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Celecoxib is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00500",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Tolmetin is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00533",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Rofecoxib is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00554",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Piroxicam is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00573",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Fenoprofen is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00580",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Valdecoxib is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00586",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Diclofenac is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00605",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Sulindac is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00712",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Flurbiprofen is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00749",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Etodolac is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00784",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Mefenamic acid is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00788",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Naproxen is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Sulfasalazine is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00812",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Phenylbutazone is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00821",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Carprofen is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00861",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Diflunisal is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00936",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Salicylic acid is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00939",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Meclofenamic acid is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00991",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Oxaprozin is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01009",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Ketoprofen is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01014",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Balsalazide is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01050",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Ibuprofen is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01250",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Olsalazine is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01283",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Lumiracoxib is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01397",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Magnesium salicylate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01399",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Salsalate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01401",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Choline magnesium trisalicylate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01419",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Antrafenine is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01424",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Aminophenazone is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01435",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Antipyrine is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01600",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Tiaprofenic acid is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01628",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Etoricoxib is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB02224",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Taxifolin is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB03585",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Oxyphenbutazone is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB04743",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Nimesulide is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB04812",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Benoxaprofen is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB04817",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Metamizole is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB04828",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Zomepirac is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB05095",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Cimicoxib is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06725",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Lornoxicam is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06736",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Aceclofenac is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06737",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Zaltoprofen is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB07402",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Azapropazone is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08439",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Parecoxib is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08797",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Salicylamide is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08940",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Kebuzone is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08942",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Isoxicam is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08951",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Indoprofen is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08955",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Ibuproxam is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08976",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Floctafenine is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08981",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Fenbufen is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08984",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Etofenamate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08991",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Epirizole is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09084",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Benzydamine is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09213",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Dexibuprofen is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09214",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Dexketoprofen is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09215",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Droxicam is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09216",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Tolfenamic acid is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09217",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Firocoxib is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09218",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Clonixin is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09285",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Morniflumate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Propacetamol is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09295",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Talniflumate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11455",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Robenacoxib is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Tepoxalin is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11518",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Flunixin is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12399",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Polmacoxib is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12445",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Nitroaspirin is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12545",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Indobufen is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12610",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Ebselen is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13001",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Tinoridine is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13167",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Alclofenac is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13217",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Fentiazac is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13232",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Suxibuzone is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13286",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Bumadizone is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13314",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Alminoprofen is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13371",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Difenpiramide is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13407",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Nifenazone is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13432",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Lonazolac is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13481",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Tenidap is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13524",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Propyphenazone is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13527",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Proglumetacin is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13538",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Guacetisal is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13544",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Ethenzamide is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13612",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Carbaspirin calcium is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13629",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Mofebutazone is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13649",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Proquazone is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13657",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Benorilate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13722",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Pirprofen is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13860",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Imidazole salicylate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB14059",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when SC 236 is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB14060",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when NS 398 is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB14938",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Flurbiprofen axetil is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09212",
                        "description": "The risk or severity of renal failure hyperkalemia and hypertension can be increased when Loxoprofen is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Tacrolimus"
                    },
                    {
                        "drugbank-id": "DB00182",
                        "description": "Amphetamine may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "Linezolid may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00614",
                        "description": "Furazolidone may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00721",
                        "description": "Procaine may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00752",
                        "description": "Tranylcypromine may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00780",
                        "description": "Phenelzine may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00805",
                        "description": "Minaprine may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01037",
                        "description": "Selegiline may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "Procarbazine may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01171",
                        "description": "Moclobemide may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01247",
                        "description": "Isocarboxazid may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01367",
                        "description": "Rasagiline may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01626",
                        "description": "Pargyline may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB04017",
                        "description": "Clorgiline may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB04818",
                        "description": "Iproniazid may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB04820",
                        "description": "Nialamide may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06654",
                        "description": "Safinamide may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08550",
                        "description": "7 8 Dichloro 1 2 3 4 tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09241",
                        "description": "Methylene blue may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09243",
                        "description": "Hydracarbazine may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09244",
                        "description": "Pirlindole may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09245",
                        "description": "Toloxatone may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09246",
                        "description": "Benmoxin may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09248",
                        "description": "Mebanazine may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09249",
                        "description": "Octamoxin may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09250",
                        "description": "Pheniprazine may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09251",
                        "description": "Phenoxypropazine may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09252",
                        "description": "Pivhydrazine may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09253",
                        "description": "Safrazine may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09254",
                        "description": "Caroxazone may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13875",
                        "description": "Harmaline may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13876",
                        "description": "Brofaromine may increase the orthostatic hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00241",
                        "description": "Butalbital may increase the hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00312",
                        "description": "Pentobarbital may increase the hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00418",
                        "description": "Secobarbital may increase the hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00474",
                        "description": "Methohexital may increase the hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00599",
                        "description": "Thiopental may increase the hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00794",
                        "description": "Primidone may increase the hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00849",
                        "description": "Methylphenobarbital may increase the hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01154",
                        "description": "Thiamylal may increase the hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01351",
                        "description": "Amobarbital may increase the hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01355",
                        "description": "Hexobarbital may increase the hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01483",
                        "description": "Barbital may increase the hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09001",
                        "description": "Barbexaclone may increase the hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00086",
                        "description": "The risk or severity of adverse effects can be increased when Streptokinase is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00232",
                        "description": "The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00268",
                        "description": "The risk or severity of adverse effects can be increased when Ropinirole is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00297",
                        "description": "The risk or severity of adverse effects can be increased when Bupivacaine is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00334",
                        "description": "The risk or severity of adverse effects can be increased when Olanzapine is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00486",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Nabilone"
                    },
                    {
                        "drugbank-id": "DB00679",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Thioridazine"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Amphotericin B"
                    },
                    {
                        "drugbank-id": "DB00703",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Methazolamide"
                    },
                    {
                        "drugbank-id": "DB00753",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Isoflurane"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Conivaptan"
                    },
                    {
                        "drugbank-id": "DB00883",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Isosorbide dinitrate"
                    },
                    {
                        "drugbank-id": "DB00903",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Etacrynic acid"
                    },
                    {
                        "drugbank-id": "DB00922",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Levosimendan"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Thalidomide"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Iloprost"
                    },
                    {
                        "drugbank-id": "DB01113",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Papaverine"
                    },
                    {
                        "drugbank-id": "DB01143",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Amifostine"
                    },
                    {
                        "drugbank-id": "DB01144",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Diclofenamide"
                    },
                    {
                        "drugbank-id": "DB01159",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Halothane"
                    },
                    {
                        "drugbank-id": "DB01189",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Desflurane"
                    },
                    {
                        "drugbank-id": "DB01236",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Sevoflurane"
                    },
                    {
                        "drugbank-id": "DB01282",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Carbetocin"
                    },
                    {
                        "drugbank-id": "DB01612",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Amyl Nitrite"
                    },
                    {
                        "drugbank-id": "DB04899",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Nesiritide"
                    },
                    {
                        "drugbank-id": "DB05271",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Rotigotine"
                    },
                    {
                        "drugbank-id": "DB06292",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Dapagliflozin"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Dinutuximab"
                    },
                    {
                        "drugbank-id": "DB09112",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Nitrous acid"
                    },
                    {
                        "drugbank-id": "DB09286",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Pipamperone"
                    },
                    {
                        "drugbank-id": "DB00310",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Chlorthalidone"
                    },
                    {
                        "drugbank-id": "DB00350",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Minoxidil"
                    },
                    {
                        "drugbank-id": "DB00436",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Bendroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00457",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Prazosin"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Doxazosin"
                    },
                    {
                        "drugbank-id": "DB00727",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Nitroglycerin"
                    },
                    {
                        "drugbank-id": "DB00774",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Hydroflumethiazide"
                    },
                    {
                        "drugbank-id": "DB00797",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Tolazoline"
                    },
                    {
                        "drugbank-id": "DB00880",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Chlorothiazide"
                    },
                    {
                        "drugbank-id": "DB00925",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Phenoxybenzamine"
                    },
                    {
                        "drugbank-id": "DB01119",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Diazoxide"
                    },
                    {
                        "drugbank-id": "DB01158",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Bretylium"
                    },
                    {
                        "drugbank-id": "DB01162",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Terazosin"
                    },
                    {
                        "drugbank-id": "DB08950",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Indoramin"
                    },
                    {
                        "drugbank-id": "DB00177",
                        "description": "The risk or severity of hyperkalemia can be increased when Valsartan is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00275",
                        "description": "The risk or severity of hyperkalemia can be increased when Olmesartan is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00678",
                        "description": "The risk or severity of hyperkalemia can be increased when Losartan is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "The risk or severity of hyperkalemia can be increased when Eprosartan is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00966",
                        "description": "The risk or severity of hyperkalemia can be increased when Telmisartan is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01029",
                        "description": "The risk or severity of hyperkalemia can be increased when Irbesartan is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01342",
                        "description": "The risk or severity of hyperkalemia can be increased when Forasartan is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01347",
                        "description": "The risk or severity of hyperkalemia can be increased when Saprisartan is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01349",
                        "description": "The risk or severity of hyperkalemia can be increased when Tasosartan is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06763",
                        "description": "The risk or severity of hyperkalemia can be increased when Saralasin is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08822",
                        "description": "The risk or severity of hyperkalemia can be increased when Azilsartan medoxomil is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09279",
                        "description": "The risk or severity of hyperkalemia can be increased when Fimasartan is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13919",
                        "description": "The risk or severity of hyperkalemia can be increased when Candesartan is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00178",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Ramipril"
                    },
                    {
                        "drugbank-id": "DB00492",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Fosinopril"
                    },
                    {
                        "drugbank-id": "DB00519",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Trandolapril"
                    },
                    {
                        "drugbank-id": "DB00542",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Benazepril"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Enalapril"
                    },
                    {
                        "drugbank-id": "DB00691",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Moexipril"
                    },
                    {
                        "drugbank-id": "DB00722",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Lisinopril"
                    },
                    {
                        "drugbank-id": "DB00790",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Perindopril"
                    },
                    {
                        "drugbank-id": "DB00881",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Quinapril"
                    },
                    {
                        "drugbank-id": "DB00886",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Omapatrilat"
                    },
                    {
                        "drugbank-id": "DB01180",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Rescinnamine"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Captopril"
                    },
                    {
                        "drugbank-id": "DB01340",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Cilazapril"
                    },
                    {
                        "drugbank-id": "DB01348",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Spirapril"
                    },
                    {
                        "drugbank-id": "DB08836",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Temocapril"
                    },
                    {
                        "drugbank-id": "DB09477",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Enalaprilat"
                    },
                    {
                        "drugbank-id": "DB11783",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Imidapril"
                    },
                    {
                        "drugbank-id": "DB13166",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Zofenopril"
                    },
                    {
                        "drugbank-id": "DB13312",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Delapril"
                    },
                    {
                        "drugbank-id": "DB14125",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Benazeprilat"
                    },
                    {
                        "drugbank-id": "DB14207",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Fosinoprilat"
                    },
                    {
                        "drugbank-id": "DB14208",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Ramiprilat"
                    },
                    {
                        "drugbank-id": "DB14209",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Trandolaprilat"
                    },
                    {
                        "drugbank-id": "DB14210",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Moexiprilat"
                    },
                    {
                        "drugbank-id": "DB14213",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Perindoprilat"
                    },
                    {
                        "drugbank-id": "DB14217",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Quinaprilat"
                    },
                    {
                        "drugbank-id": "DB14231",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Quinoline Yellow WS"
                    },
                    {
                        "drugbank-id": "DB15565",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Cilazaprilat"
                    },
                    {
                        "drugbank-id": "DB00714",
                        "description": "The metabolism of Apomorphine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00184",
                        "description": "The metabolism of Nicotine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00214",
                        "description": "The metabolism of Torasemide can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Lovastatin can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00250",
                        "description": "The metabolism of Dapsone can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "The metabolism of Diethylstilbestrol can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Theophylline can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00295",
                        "description": "The metabolism of Morphine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00333",
                        "description": "The metabolism of Methadone can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00338",
                        "description": "The metabolism of Omeprazole can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00343",
                        "description": "The metabolism of Diltiazem can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00347",
                        "description": "The metabolism of Trimethadione can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00359",
                        "description": "The metabolism of Sulfadiazine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The metabolism of Eszopiclone can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00412",
                        "description": "The metabolism of Rosiglitazone can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The metabolism of Cerivastatin can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00448",
                        "description": "The metabolism of Lansoprazole can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The metabolism of Quinine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The metabolism of Zidovudine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The metabolism of Cyclophosphamide can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00532",
                        "description": "The metabolism of Mephenytoin can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00549",
                        "description": "The metabolism of Zafirlukast can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The metabolism of Cisapride can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The metabolism of Chloroquine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00613",
                        "description": "The metabolism of Amodiaquine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00617",
                        "description": "The metabolism of Paramethadione can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "The metabolism of Imatinib can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00622",
                        "description": "The metabolism of Nicardipine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The metabolism of Simvastatin can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "The metabolism of Mycophenolate mofetil can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "The metabolism of Tretinoin can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "The metabolism of Estradiol can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00799",
                        "description": "The metabolism of Tazarotene can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The metabolism of Propofol can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00836",
                        "description": "The metabolism of Loperamide can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The metabolism of Terbinafine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00912",
                        "description": "The metabolism of Repaglinide can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00918",
                        "description": "The metabolism of Almotriptan can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00921",
                        "description": "The metabolism of Buprenorphine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00972",
                        "description": "The metabolism of Azelastine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The metabolism of Atorvastatin can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The metabolism of Fluvastatin can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01124",
                        "description": "The metabolism of Tolbutamide can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01132",
                        "description": "The metabolism of Pioglitazone can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The metabolism of Ifosfamide can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01184",
                        "description": "The metabolism of Domperidone can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The metabolism of Zopiclone can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01218",
                        "description": "The metabolism of Halofantrine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01221",
                        "description": "The metabolism of Ketamine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01259",
                        "description": "The metabolism of Lapatinib can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01261",
                        "description": "The metabolism of Sitagliptin can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01357",
                        "description": "The metabolism of Mestranol can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB04725",
                        "description": "The metabolism of Licofelone can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB05229",
                        "description": "The metabolism of Beraprost can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06210",
                        "description": "The metabolism of Eltrombopag can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06510",
                        "description": "The metabolism of Muraglitazar can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06605",
                        "description": "The metabolism of Apixaban can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06670",
                        "description": "The metabolism of Odanacatib can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06738",
                        "description": "The metabolism of Ketobemidone can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06739",
                        "description": "The metabolism of Seratrodast can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06770",
                        "description": "The metabolism of Benzyl alcohol can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The metabolism of R warfarin can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08860",
                        "description": "The metabolism of Pitavastatin can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08899",
                        "description": "The metabolism of Enzalutamide can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08918",
                        "description": "The metabolism of Levomilnacipran can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08922",
                        "description": "The metabolism of Perospirone can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08931",
                        "description": "The metabolism of Riociguat can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09068",
                        "description": "The metabolism of Vortioxetine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09183",
                        "description": "The metabolism of Dasabuvir can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09198",
                        "description": "The metabolism of Lobeglitazone can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09199",
                        "description": "The metabolism of Netoglitazone can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09200",
                        "description": "The metabolism of Rivoglitazone can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09201",
                        "description": "The metabolism of Ciglitazone can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09296",
                        "description": "The metabolism of Ombitasvir can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11362",
                        "description": "The metabolism of Selexipag can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11613",
                        "description": "The metabolism of Velpatasvir can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11901",
                        "description": "The metabolism of Apalutamide can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11978",
                        "description": "The metabolism of Glasdegib can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11979",
                        "description": "The metabolism of Elagolix can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12026",
                        "description": "The metabolism of Voxilaprevir can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12130",
                        "description": "The metabolism of Lorlatinib can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12781",
                        "description": "The metabolism of Balaglitazone can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13943",
                        "description": "The metabolism of Testosterone cypionate can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13944",
                        "description": "The metabolism of Testosterone enanthate can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13946",
                        "description": "The metabolism of Testosterone undecanoate can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "The metabolism of Estradiol acetate can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "The metabolism of Estradiol benzoate can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "The metabolism of Estradiol cypionate can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13955",
                        "description": "The metabolism of Estradiol dienanthate can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "The metabolism of Estradiol valerate can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The metabolism of S Warfarin can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11757",
                        "description": "The metabolism of Istradefylline can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00471",
                        "description": "The metabolism of Montelukast can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08502",
                        "description": "The metabolism of Capravirine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01217",
                        "description": "The metabolism of Anastrozole can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00661",
                        "description": "The metabolism of Verapamil can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00321",
                        "description": "The metabolism of Amitriptyline can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12612",
                        "description": "The metabolism of Ozanimod can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11652",
                        "description": "The metabolism of Tucatinib can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11689",
                        "description": "The metabolism of Selumetinib can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "The metabolism of Hydroxychloroquine can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00187",
                        "description": "The risk or severity of hyperkalemia can be increased when Esmolol is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00195",
                        "description": "The risk or severity of hyperkalemia can be increased when Betaxolol is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00202",
                        "description": "The risk or severity of hyperkalemia can be increased when Succinylcholine is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00381",
                        "description": "The risk or severity of hyperkalemia can be increased when Amlodipine is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00384",
                        "description": "The risk or severity of hyperkalemia can be increased when Triamterene is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00393",
                        "description": "The risk or severity of hyperkalemia can be increased when Nimodipine is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00407",
                        "description": "The risk or severity of hyperkalemia can be increased when Ardeparin is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00489",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Sotalol"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Lercanidipine"
                    },
                    {
                        "drugbank-id": "DB00568",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Cinnarizine"
                    },
                    {
                        "drugbank-id": "DB00593",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Ethosuximide"
                    },
                    {
                        "drugbank-id": "DB00594",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Amiloride"
                    },
                    {
                        "drugbank-id": "DB00700",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Eplerenone"
                    },
                    {
                        "drugbank-id": "DB00825",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Levomenthol"
                    },
                    {
                        "drugbank-id": "DB00866",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Alprenolol"
                    },
                    {
                        "drugbank-id": "DB01074",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Perhexiline"
                    },
                    {
                        "drugbank-id": "DB01109",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Heparin"
                    },
                    {
                        "drugbank-id": "DB01136",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Carvedilol"
                    },
                    {
                        "drugbank-id": "DB01167",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Itraconazole"
                    },
                    {
                        "drugbank-id": "DB01182",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Propafenone"
                    },
                    {
                        "drugbank-id": "DB01193",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Acebutolol"
                    },
                    {
                        "drugbank-id": "DB01219",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Dantrolene"
                    },
                    {
                        "drugbank-id": "DB01225",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Enoxaparin"
                    },
                    {
                        "drugbank-id": "DB01244",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Bepridil"
                    },
                    {
                        "drugbank-id": "DB01295",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Bevantolol"
                    },
                    {
                        "drugbank-id": "DB01297",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Practolol"
                    },
                    {
                        "drugbank-id": "DB01388",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Mibefradil"
                    },
                    {
                        "drugbank-id": "DB01580",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Oxprenolol"
                    },
                    {
                        "drugbank-id": "DB02968",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Penicillin G Acyl Serine"
                    },
                    {
                        "drugbank-id": "DB04825",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Prenylamine"
                    },
                    {
                        "drugbank-id": "DB04838",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Cyclandelate"
                    },
                    {
                        "drugbank-id": "DB04841",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Flunarizine"
                    },
                    {
                        "drugbank-id": "DB04842",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Fluspirilene"
                    },
                    {
                        "drugbank-id": "DB05246",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Methsuximide"
                    },
                    {
                        "drugbank-id": "DB05885",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Seletracetam"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Tolvaptan"
                    },
                    {
                        "drugbank-id": "DB06271",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Sulodexide"
                    },
                    {
                        "drugbank-id": "DB06446",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Dotarizine"
                    },
                    {
                        "drugbank-id": "DB06712",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Nilvadipine"
                    },
                    {
                        "drugbank-id": "DB06726",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Bufuralol"
                    },
                    {
                        "drugbank-id": "DB06754",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Danaparoid"
                    },
                    {
                        "drugbank-id": "DB06779",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Dalteparin"
                    },
                    {
                        "drugbank-id": "DB06822",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Tinzaparin"
                    },
                    {
                        "drugbank-id": "DB07615",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Tranilast"
                    },
                    {
                        "drugbank-id": "DB08807",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Bopindolol"
                    },
                    {
                        "drugbank-id": "DB08808",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Bupranolol"
                    },
                    {
                        "drugbank-id": "DB08813",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Nadroparin"
                    },
                    {
                        "drugbank-id": "DB08838",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Agmatine"
                    },
                    {
                        "drugbank-id": "DB08952",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Indenolol"
                    },
                    {
                        "drugbank-id": "DB08980",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Fendiline"
                    },
                    {
                        "drugbank-id": "DB08992",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Eperisone"
                    },
                    {
                        "drugbank-id": "DB09015",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Canrenoic acid"
                    },
                    {
                        "drugbank-id": "DB09026",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Aliskiren"
                    },
                    {
                        "drugbank-id": "DB09090",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Pinaverium"
                    },
                    {
                        "drugbank-id": "DB09227",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Barnidipine"
                    },
                    {
                        "drugbank-id": "DB09229",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Aranidipine"
                    },
                    {
                        "drugbank-id": "DB09230",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Azelnidipine"
                    },
                    {
                        "drugbank-id": "DB09231",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Benidipine"
                    },
                    {
                        "drugbank-id": "DB09232",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Cilnidipine"
                    },
                    {
                        "drugbank-id": "DB09234",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Darodipine"
                    },
                    {
                        "drugbank-id": "DB09235",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Efonidipine"
                    },
                    {
                        "drugbank-id": "DB09238",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Manidipine"
                    },
                    {
                        "drugbank-id": "DB09239",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Niguldipine"
                    },
                    {
                        "drugbank-id": "DB09240",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Niludipine"
                    },
                    {
                        "drugbank-id": "DB09258",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Bemiparin"
                    },
                    {
                        "drugbank-id": "DB09259",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Reviparin"
                    },
                    {
                        "drugbank-id": "DB09260",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Parnaparin"
                    },
                    {
                        "drugbank-id": "DB09261",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Certoparin"
                    },
                    {
                        "drugbank-id": "DB09351",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Levobetaxolol"
                    },
                    {
                        "drugbank-id": "DB11770",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Talinolol"
                    },
                    {
                        "drugbank-id": "DB11960",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Carboxyamidotriazole"
                    },
                    {
                        "drugbank-id": "DB12092",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Naftopidil"
                    },
                    {
                        "drugbank-id": "DB12093",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Tetrahydropalmatine"
                    },
                    {
                        "drugbank-id": "DB12097",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Mannitol busulfan"
                    },
                    {
                        "drugbank-id": "DB12131",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Vinpocetine"
                    },
                    {
                        "drugbank-id": "DB12212",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Landiolol"
                    },
                    {
                        "drugbank-id": "DB12221",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Canrenone"
                    },
                    {
                        "drugbank-id": "DB12752",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Bucindolol"
                    },
                    {
                        "drugbank-id": "DB12923",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Gallopamil"
                    },
                    {
                        "drugbank-id": "DB13443",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Esatenolol"
                    },
                    {
                        "drugbank-id": "DB13488",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Bencyclane"
                    },
                    {
                        "drugbank-id": "DB13500",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Otilonium"
                    },
                    {
                        "drugbank-id": "DB13508",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Cloranolol"
                    },
                    {
                        "drugbank-id": "DB13530",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Mepindolol"
                    },
                    {
                        "drugbank-id": "DB13725",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Terodiline"
                    },
                    {
                        "drugbank-id": "DB13757",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Epanolol"
                    },
                    {
                        "drugbank-id": "DB13766",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Lidoflazine"
                    },
                    {
                        "drugbank-id": "DB13775",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Tertatolol"
                    },
                    {
                        "drugbank-id": "DB13791",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Penfluridol"
                    },
                    {
                        "drugbank-id": "DB13835",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Caroverine"
                    },
                    {
                        "drugbank-id": "DB13950",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with WIN 55212 2"
                    },
                    {
                        "drugbank-id": "DB13961",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Fish oil"
                    },
                    {
                        "drugbank-id": "DB14063",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Dexverapamil"
                    },
                    {
                        "drugbank-id": "DB14064",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Emopamil"
                    },
                    {
                        "drugbank-id": "DB14065",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Lomerizine"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB14068",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Dexniguldipine"
                    },
                    {
                        "drugbank-id": "DB00738",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Pentamidine"
                    },
                    {
                        "drugbank-id": "DB09449",
                        "description": "Spironolactone may increase the nephrotoxic activities of Sodium phosphate monobasic"
                    },
                    {
                        "drugbank-id": "DB00796",
                        "description": "The risk or severity of hypotension and hyperkalemia can be increased when Candesartan cilexetil is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13783",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Acemetacin"
                    },
                    {
                        "drugbank-id": "DB09236",
                        "description": "Spironolactone may increase the hypotensive activities of Lacidipine"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "Ethanol may increase the hypotensive activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00761",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium chloride is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06715",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium Iodide is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09087",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium alum is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09125",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium citrate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09413",
                        "description": "The risk or severity of hyperkalemia can be increased when Monopotassium phosphate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09414",
                        "description": "The risk or severity of hyperkalemia can be increased when Dipotassium phosphate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium perchlorate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09483",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium lactate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11090",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium nitrate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11098",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium bicarbonate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11107",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium bitartrate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11153",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium hydroxide is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13620",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium gluconate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13735",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium guaiacolsulfonate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13831",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium permanganate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13977",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium carbonate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB14492",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium triiodide is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB14498",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB14499",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium sulfate is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01345",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Potassium cation"
                    },
                    {
                        "drugbank-id": "DB00653",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Magnesium sulfate"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Lactulose"
                    },
                    {
                        "drugbank-id": "DB00742",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Mannitol"
                    },
                    {
                        "drugbank-id": "DB01046",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Lubiprostone"
                    },
                    {
                        "drugbank-id": "DB01079",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Tegaserod"
                    },
                    {
                        "drugbank-id": "DB01377",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Magnesium oxide"
                    },
                    {
                        "drugbank-id": "DB01378",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Magnesium cation"
                    },
                    {
                        "drugbank-id": "DB01593",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Zinc"
                    },
                    {
                        "drugbank-id": "DB01638",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Sorbitol"
                    },
                    {
                        "drugbank-id": "DB04816",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Dantron"
                    },
                    {
                        "drugbank-id": "DB04823",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Oxyphenisatin"
                    },
                    {
                        "drugbank-id": "DB04824",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Phenolphthalein"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Prucalopride"
                    },
                    {
                        "drugbank-id": "DB07715",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Emodin"
                    },
                    {
                        "drugbank-id": "DB08890",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Linaclotide"
                    },
                    {
                        "drugbank-id": "DB09020",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Bisacodyl"
                    },
                    {
                        "drugbank-id": "DB09104",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Magnesium hydroxide"
                    },
                    {
                        "drugbank-id": "DB09219",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Bisoxatin"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Picosulfuric acid"
                    },
                    {
                        "drugbank-id": "DB09281",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Magnesium trisilicate"
                    },
                    {
                        "drugbank-id": "DB09287",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Polyethylene glycol"
                    },
                    {
                        "drugbank-id": "DB09311",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Polycarbophil"
                    },
                    {
                        "drugbank-id": "DB09409",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Magnesium acetate tetrahydrate"
                    },
                    {
                        "drugbank-id": "DB09462",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Glycerin"
                    },
                    {
                        "drugbank-id": "DB09472",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Sodium sulfate"
                    },
                    {
                        "drugbank-id": "DB09481",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Magnesium carbonate"
                    },
                    {
                        "drugbank-id": "DB09484",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Sodium fluorophosphate"
                    },
                    {
                        "drugbank-id": "DB11057",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Mineral oil"
                    },
                    {
                        "drugbank-id": "DB11059",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Carboxymethylcellulose"
                    },
                    {
                        "drugbank-id": "DB11089",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Docusate"
                    },
                    {
                        "drugbank-id": "DB11097",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Plantago seed"
                    },
                    {
                        "drugbank-id": "DB11110",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Magnesium citrate"
                    },
                    {
                        "drugbank-id": "DB11113",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Castor oil"
                    },
                    {
                        "drugbank-id": "DB11189",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Magnesium glycinate"
                    },
                    {
                        "drugbank-id": "DB11228",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Methylcellulose"
                    },
                    {
                        "drugbank-id": "DB11365",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Sennosides"
                    },
                    {
                        "drugbank-id": "DB12942",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Lactitol"
                    },
                    {
                        "drugbank-id": "DB13170",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Plecanatide"
                    },
                    {
                        "drugbank-id": "DB13180",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Gluconic Acid"
                    },
                    {
                        "drugbank-id": "DB13486",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Magnesium peroxide"
                    },
                    {
                        "drugbank-id": "DB13526",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Pentaerithrityl"
                    },
                    {
                        "drugbank-id": "DB13707",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Sodium tartrate"
                    },
                    {
                        "drugbank-id": "DB13996",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Magnesium acetate"
                    },
                    {
                        "drugbank-id": "DB14232",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Deacetylbisacodyl"
                    },
                    {
                        "drugbank-id": "DB14482",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Sodium ascorbate"
                    },
                    {
                        "drugbank-id": "DB14502",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Sodium phosphate dibasic"
                    },
                    {
                        "drugbank-id": "DB14503",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Sodium phosphate monobasic unspecified form"
                    },
                    {
                        "drugbank-id": "DB14504",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Sodium phosphate dibasic unspecified form"
                    },
                    {
                        "drugbank-id": "DB14516",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Sodium cation"
                    },
                    {
                        "drugbank-id": "DB14585",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Plantago ovata seed"
                    },
                    {
                        "drugbank-id": "DB14627",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Oxyphenisatin acetate"
                    },
                    {
                        "drugbank-id": "DB14684",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Calcium polycarbophil"
                    },
                    {
                        "drugbank-id": "DB14963",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Konjac mannan"
                    },
                    {
                        "drugbank-id": "DB15477",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Alloin"
                    },
                    {
                        "drugbank-id": "DB15478",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Frangula purshiana bark"
                    },
                    {
                        "drugbank-id": "DB11622",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Dehydrocholic acid"
                    },
                    {
                        "drugbank-id": "DB14546",
                        "description": "The risk or severity of adverse effects can be increased when Spironolactone is combined with Sulfate ion"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "Dexamethasone may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB03619",
                        "description": "Deoxycholic acid may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04348",
                        "description": "Taurocholic acid may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01174",
                        "description": "Phenobarbital may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00975",
                        "description": "Spironolactone may decrease the excretion rate of Dipyridamole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00335",
                        "description": "Atenolol may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01023",
                        "description": "Spironolactone may decrease the excretion rate of Felodipine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01054",
                        "description": "Spironolactone may decrease the excretion rate of Nitrendipine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "Pravastatin may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00220",
                        "description": "Nelfinavir may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00222",
                        "description": "Glimepiride may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "Indinavir may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00301",
                        "description": "Flucloxacillin may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "Terfenadine may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "Spironolactone may decrease the excretion rate of Ritonavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00572",
                        "description": "Spironolactone may decrease the excretion rate of Atropine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00625",
                        "description": "Spironolactone may decrease the excretion rate of Efavirenz which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00693",
                        "description": "Spironolactone may decrease the excretion rate of Fluorescein which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00822",
                        "description": "Spironolactone may decrease the excretion rate of Disulfiram which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00834",
                        "description": "Spironolactone may decrease the excretion rate of Mifepristone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00973",
                        "description": "Spironolactone may decrease the excretion rate of Ezetimibe which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "Spironolactone may decrease the excretion rate of Atazanavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "Spironolactone may decrease the excretion rate of Rosuvastatin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01138",
                        "description": "Spironolactone may decrease the excretion rate of Sulfinpyrazone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "Spironolactone may decrease the excretion rate of Ofloxacin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01211",
                        "description": "Spironolactone may decrease the excretion rate of Clarithromycin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "Spironolactone may decrease the excretion rate of Saquinavir which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB05804",
                        "description": "Spironolactone may decrease the excretion rate of Prasterone sulfate which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB09374",
                        "description": "Spironolactone may decrease the excretion rate of Indocyanine green acid form which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12319",
                        "description": "Spironolactone may decrease the excretion rate of Benzbromarone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB12712",
                        "description": "Spironolactone may decrease the excretion rate of Pilsicainide which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "Spironolactone may decrease the excretion rate of Dihydroergocristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB13751",
                        "description": "Spironolactone may decrease the excretion rate of Glycyrrhizic acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB02123",
                        "description": "Spironolactone may decrease the excretion rate of Glycochenodeoxycholic Acid which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00455",
                        "description": "Spironolactone may decrease the excretion rate of Loratadine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "Indomethacin may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "Spironolactone may decrease the excretion rate of Belantamab mafodotin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "Vinblastine may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "Spironolactone may decrease the excretion rate of Astemizole which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "Spironolactone may decrease the excretion rate of Daunorubicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "Spironolactone may decrease the excretion rate of Vincristine which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "Spironolactone may decrease the excretion rate of Doxorubicin which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "Aldesleukin may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00296",
                        "description": "Ropivacaine may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00323",
                        "description": "Tolcapone may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00413",
                        "description": "Pramipexole may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00435",
                        "description": "Spironolactone may increase the excretion rate of Nitric Oxide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "Spironolactone may increase the excretion rate of Clofarabine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00695",
                        "description": "Spironolactone may increase the excretion rate of Furosemide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00706",
                        "description": "Spironolactone may increase the excretion rate of Tamsulosin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "Spironolactone may increase the excretion rate of Bumetanide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01002",
                        "description": "Spironolactone may increase the excretion rate of Levobupivacaine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01020",
                        "description": "Spironolactone may increase the excretion rate of Isosorbide mononitrate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09292",
                        "description": "Spironolactone may increase the excretion rate of Sacubitril which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00196",
                        "description": "Fluconazole may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "Metoprolol may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00270",
                        "description": "Isradipine may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00373",
                        "description": "Timolol may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00401",
                        "description": "Nisoldipine may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "Spironolactone may increase the excretion rate of Trimethoprim which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00555",
                        "description": "Spironolactone may increase the excretion rate of Lamotrigine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00571",
                        "description": "Spironolactone may increase the excretion rate of Propranolol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00598",
                        "description": "Spironolactone may increase the excretion rate of Labetalol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00612",
                        "description": "Spironolactone may increase the excretion rate of Bisoprolol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00909",
                        "description": "Spironolactone may increase the excretion rate of Zonisamide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00960",
                        "description": "Spironolactone may increase the excretion rate of Pindolol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "Spironolactone may increase the excretion rate of Sulfamethoxazole which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01115",
                        "description": "Spironolactone may increase the excretion rate of Nifedipine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01203",
                        "description": "Spironolactone may increase the excretion rate of Nadolol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01359",
                        "description": "Spironolactone may increase the excretion rate of Penbutolol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04920",
                        "description": "Spironolactone may increase the excretion rate of Clevidipine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06767",
                        "description": "Spironolactone may increase the excretion rate of Ammonium chloride which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08907",
                        "description": "Spironolactone may increase the excretion rate of Canagliflozin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09089",
                        "description": "Spironolactone may increase the excretion rate of Trimebutine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09204",
                        "description": "Spironolactone may increase the excretion rate of Arotinolol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00325",
                        "description": "Spironolactone may increase the excretion rate of Nitroprusside which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00524",
                        "description": "Spironolactone may increase the excretion rate of Metolazone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00657",
                        "description": "Spironolactone may increase the excretion rate of Mecamylamine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00692",
                        "description": "Spironolactone may increase the excretion rate of Phentolamine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00800",
                        "description": "Spironolactone may increase the excretion rate of Fenoldopam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00808",
                        "description": "Spironolactone may increase the excretion rate of Indapamide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00820",
                        "description": "Spironolactone may increase the excretion rate of Tadalafil which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01170",
                        "description": "Spironolactone may increase the excretion rate of Guanethidine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01240",
                        "description": "Spironolactone may increase the excretion rate of Epoprostenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01275",
                        "description": "Spironolactone may increase the excretion rate of Hydralazine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08932",
                        "description": "Spironolactone may increase the excretion rate of Macitentan which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00176",
                        "description": "Fluvoxamine may increase the excretion rate of Spironolactone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00833",
                        "description": "Spironolactone may increase the excretion rate of Cefaclor which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00911",
                        "description": "Spironolactone may increase the excretion rate of Tinidazole which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "Spironolactone may increase the excretion rate of Fenofibrate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01067",
                        "description": "Spironolactone may increase the excretion rate of Glipizide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01149",
                        "description": "Spironolactone may increase the excretion rate of Nefazodone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "Spironolactone may increase the excretion rate of Budesonide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "Spironolactone may increase the excretion rate of Leuprolide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00014",
                        "description": "Spironolactone may increase the excretion rate of Goserelin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00017",
                        "description": "Spironolactone may increase the excretion rate of Salmon calcitonin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00035",
                        "description": "Spironolactone may increase the excretion rate of Desmopressin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00080",
                        "description": "Spironolactone may increase the excretion rate of Daptomycin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "Spironolactone may increase the excretion rate of Tositumomab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00115",
                        "description": "Spironolactone may increase the excretion rate of Cyanocobalamin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00158",
                        "description": "Spironolactone may increase the excretion rate of Folic acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00165",
                        "description": "Spironolactone may increase the excretion rate of Pyridoxine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "Spironolactone may increase the excretion rate of Baclofen which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00185",
                        "description": "Spironolactone may increase the excretion rate of Cevimeline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "Spironolactone may increase the excretion rate of Lorazepam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00190",
                        "description": "Spironolactone may increase the excretion rate of Carbidopa which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00198",
                        "description": "Spironolactone may increase the excretion rate of Oseltamivir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00200",
                        "description": "Spironolactone may increase the excretion rate of Hydroxocobalamin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "Spironolactone may increase the excretion rate of Ticlopidine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00213",
                        "description": "Spironolactone may increase the excretion rate of Pantoprazole which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00225",
                        "description": "Spironolactone may increase the excretion rate of Gadodiamide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00235",
                        "description": "Spironolactone may increase the excretion rate of Milrinone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00237",
                        "description": "Spironolactone may increase the excretion rate of Butabarbital which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00243",
                        "description": "Spironolactone may increase the excretion rate of Ranolazine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00245",
                        "description": "Spironolactone may increase the excretion rate of Benzatropine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "Spironolactone may increase the excretion rate of Doxycycline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "Spironolactone may increase the excretion rate of Carmustine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00271",
                        "description": "Spironolactone may increase the excretion rate of Diatrizoate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00273",
                        "description": "Spironolactone may increase the excretion rate of Topiramate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "Spironolactone may increase the excretion rate of Liothyronine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "Spironolactone may increase the excretion rate of Disopyramide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00284",
                        "description": "Spironolactone may increase the excretion rate of Acarbose which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00285",
                        "description": "Spironolactone may increase the excretion rate of Venlafaxine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Spironolactone may increase the excretion rate of Conjugated estrogens which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00289",
                        "description": "Spironolactone may increase the excretion rate of Atomoxetine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "Spironolactone may increase the excretion rate of Bleomycin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00294",
                        "description": "Spironolactone may increase the excretion rate of Etonogestrel which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00300",
                        "description": "Spironolactone may increase the excretion rate of Tenofovir disoproxil which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00303",
                        "description": "Spironolactone may increase the excretion rate of Ertapenem which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00308",
                        "description": "Spironolactone may increase the excretion rate of Ibutilide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "Spironolactone may increase the excretion rate of Acetaminophen which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00319",
                        "description": "Spironolactone may increase the excretion rate of Piperacillin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "Spironolactone may increase the excretion rate of Floxuridine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00330",
                        "description": "Spironolactone may increase the excretion rate of Ethambutol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00331",
                        "description": "Spironolactone may increase the excretion rate of Metformin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00339",
                        "description": "Spironolactone may increase the excretion rate of Pyrazinamide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00341",
                        "description": "Spironolactone may increase the excretion rate of Cetirizine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00349",
                        "description": "Spironolactone may increase the excretion rate of Clobazam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "Spironolactone may increase the excretion rate of Megestrol acetate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00355",
                        "description": "Spironolactone may increase the excretion rate of Aztreonam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00356",
                        "description": "Spironolactone may increase the excretion rate of Chlorzoxazone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00364",
                        "description": "Spironolactone may increase the excretion rate of Sucralfate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00369",
                        "description": "Spironolactone may increase the excretion rate of Cidofovir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00372",
                        "description": "Spironolactone may increase the excretion rate of Thiethylperazine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00377",
                        "description": "Spironolactone may increase the excretion rate of Palonosetron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "Spironolactone may increase the excretion rate of Dexrazoxane which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "Spironolactone may increase the excretion rate of Alprazolam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00415",
                        "description": "Spironolactone may increase the excretion rate of Ampicillin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00422",
                        "description": "Spironolactone may increase the excretion rate of Methylphenidate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "Spironolactone may increase the excretion rate of Trifluridine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00437",
                        "description": "Spironolactone may increase the excretion rate of Allopurinol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00438",
                        "description": "Spironolactone may increase the excretion rate of Ceftazidime which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "Spironolactone may increase the excretion rate of Gemcitabine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "Spironolactone may increase the excretion rate of Lenalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "Spironolactone may increase the excretion rate of Buspirone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00499",
                        "description": "Spironolactone may increase the excretion rate of Flutamide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "Spironolactone may increase the excretion rate of Haloperidol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00535",
                        "description": "Spironolactone may increase the excretion rate of Cefdinir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00548",
                        "description": "Spironolactone may increase the excretion rate of Azelaic acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "Spironolactone may increase the excretion rate of Pentostatin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00553",
                        "description": "Spironolactone may increase the excretion rate of Methoxsalen which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00558",
                        "description": "Spironolactone may increase the excretion rate of Zanamivir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "Spironolactone may increase the excretion rate of Methotrexate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "Spironolactone may increase the excretion rate of Cephalexin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00569",
                        "description": "Spironolactone may increase the excretion rate of Fondaparinux which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00577",
                        "description": "Spironolactone may increase the excretion rate of Valaciclovir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00583",
                        "description": "Spironolactone may increase the excretion rate of Levocarnitine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "Spironolactone may increase the excretion rate of Fluocinolone acetonide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00597",
                        "description": "Spironolactone may increase the excretion rate of Gadoteridol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "Spironolactone may increase the excretion rate of Medroxyprogesterone acetate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00628",
                        "description": "Spironolactone may increase the excretion rate of Clorazepic acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "Spironolactone may increase the excretion rate of Prednisone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00651",
                        "description": "Spironolactone may increase the excretion rate of Dyphylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00660",
                        "description": "Spironolactone may increase the excretion rate of Metaxalone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00665",
                        "description": "Spironolactone may increase the excretion rate of Nilutamide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00669",
                        "description": "Spironolactone may increase the excretion rate of Sumatriptan which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00672",
                        "description": "Spironolactone may increase the excretion rate of Chlorpropamide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "Spironolactone may increase the excretion rate of Midazolam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00690",
                        "description": "Spironolactone may increase the excretion rate of Flurazepam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "Spironolactone may increase the excretion rate of Lamivudine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00713",
                        "description": "Spironolactone may increase the excretion rate of Oxacillin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00716",
                        "description": "Spironolactone may increase the excretion rate of Nedocromil which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00730",
                        "description": "Spironolactone may increase the excretion rate of Thiabendazole which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00731",
                        "description": "Spironolactone may increase the excretion rate of Nateglinide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00733",
                        "description": "Spironolactone may increase the excretion rate of Pralidoxime which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00743",
                        "description": "Spironolactone may increase the excretion rate of Gadobenic acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "Spironolactone may increase the excretion rate of Tetracycline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00760",
                        "description": "Spironolactone may increase the excretion rate of Meropenem which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "Spironolactone may increase the excretion rate of Methimazole which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00775",
                        "description": "Spironolactone may increase the excretion rate of Tirofiban which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00782",
                        "description": "Spironolactone may increase the excretion rate of Propantheline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00787",
                        "description": "Spironolactone may increase the excretion rate of Acyclovir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00789",
                        "description": "Spironolactone may increase the excretion rate of Gadopentetic acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00804",
                        "description": "Spironolactone may increase the excretion rate of Dicyclomine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "Spironolactone may increase the excretion rate of Pentoxifylline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00811",
                        "description": "Spironolactone may increase the excretion rate of Ribavirin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00828",
                        "description": "Spironolactone may increase the excretion rate of Fosfomycin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00839",
                        "description": "Spironolactone may increase the excretion rate of Tolazamide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00842",
                        "description": "Spironolactone may increase the excretion rate of Oxazepam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "Spironolactone may increase the excretion rate of Dacarbazine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "Spironolactone may increase the excretion rate of Temozolomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "Spironolactone may increase the excretion rate of Ranitidine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00894",
                        "description": "Spironolactone may increase the excretion rate of Testolactone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "Spironolactone may increase the excretion rate of Triazolam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00900",
                        "description": "Spironolactone may increase the excretion rate of Didanosine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00915",
                        "description": "Spironolactone may increase the excretion rate of Amantadine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "Spironolactone may increase the excretion rate of Azacitidine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00934",
                        "description": "Spironolactone may increase the excretion rate of Maprotiline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "Spironolactone may increase the excretion rate of Isoniazid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00953",
                        "description": "Spironolactone may increase the excretion rate of Rizatriptan which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "Spironolactone may increase the excretion rate of Carboplatin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00961",
                        "description": "Spironolactone may increase the excretion rate of Mepivacaine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00962",
                        "description": "Spironolactone may increase the excretion rate of Zaleplon which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00980",
                        "description": "Spironolactone may increase the excretion rate of Ramelteon which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00988",
                        "description": "Spironolactone may increase the excretion rate of Dopamine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "Spironolactone may increase the excretion rate of Azathioprine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00995",
                        "description": "Spironolactone may increase the excretion rate of Auranofin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "Spironolactone may increase the excretion rate of Ganciclovir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01010",
                        "description": "Spironolactone may increase the excretion rate of Edrophonium which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01011",
                        "description": "Spironolactone may increase the excretion rate of Metyrapone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01022",
                        "description": "Spironolactone may increase the excretion rate of Phylloquinone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "Spironolactone may increase the excretion rate of Mycophenolic acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "Spironolactone may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01032",
                        "description": "Spironolactone may increase the excretion rate of Probenecid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01036",
                        "description": "Spironolactone may increase the excretion rate of Tolterodine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01043",
                        "description": "Spironolactone may increase the excretion rate of Memantine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01048",
                        "description": "Spironolactone may increase the excretion rate of Abacavir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01060",
                        "description": "Spironolactone may increase the excretion rate of Amoxicillin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01068",
                        "description": "Spironolactone may increase the excretion rate of Clonazepam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01069",
                        "description": "Spironolactone may increase the excretion rate of Promethazine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01093",
                        "description": "Spironolactone may increase the excretion rate of Dimethyl sulfoxide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "Spironolactone may increase the excretion rate of Flucytosine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "Spironolactone may increase the excretion rate of Capecitabine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01105",
                        "description": "Spironolactone may increase the excretion rate of Sibutramine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01129",
                        "description": "Spironolactone may increase the excretion rate of Rabeprazole which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01133",
                        "description": "Spironolactone may increase the excretion rate of Tiludronic acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01137",
                        "description": "Spironolactone may increase the excretion rate of Levofloxacin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01140",
                        "description": "Spironolactone may increase the excretion rate of Cefadroxil which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01148",
                        "description": "Spironolactone may increase the excretion rate of Flavoxate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01157",
                        "description": "Spironolactone may increase the excretion rate of Trimetrexate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "Spironolactone may increase the excretion rate of Cilostazol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "Spironolactone may increase the excretion rate of Arsenic trioxide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01205",
                        "description": "Spironolactone may increase the excretion rate of Flumazenil which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01212",
                        "description": "Spironolactone may increase the excretion rate of Ceftriaxone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01213",
                        "description": "Spironolactone may increase the excretion rate of Fomepizole which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "Spironolactone may increase the excretion rate of Estazolam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01224",
                        "description": "Spironolactone may increase the excretion rate of Quetiapine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "Spironolactone may increase the excretion rate of Metoclopramide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "Spironolactone may increase the excretion rate of Gemfibrozil which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01249",
                        "description": "Spironolactone may increase the excretion rate of Iodixanol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01273",
                        "description": "Spironolactone may increase the excretion rate of Varenicline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01330",
                        "description": "Spironolactone may increase the excretion rate of Cefotetan which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01333",
                        "description": "Spironolactone may increase the excretion rate of Cefradine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "Spironolactone may increase the excretion rate of Colchicine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01409",
                        "description": "Spironolactone may increase the excretion rate of Tiotropium which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01415",
                        "description": "Spironolactone may increase the excretion rate of Ceftibuten which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01420",
                        "description": "Spironolactone may increase the excretion rate of Testosterone propionate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01427",
                        "description": "Spironolactone may increase the excretion rate of Amrinone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01428",
                        "description": "Spironolactone may increase the excretion rate of Oxybenzone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "Spironolactone may increase the excretion rate of Allylestrenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01550",
                        "description": "Spironolactone may increase the excretion rate of Fenproporex which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01558",
                        "description": "Spironolactone may increase the excretion rate of Bromazepam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01563",
                        "description": "Spironolactone may increase the excretion rate of Chloral hydrate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01587",
                        "description": "Spironolactone may increase the excretion rate of Ketazolam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01610",
                        "description": "Spironolactone may increase the excretion rate of Valganciclovir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "Spironolactone may increase the excretion rate of Roflumilast which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01685",
                        "description": "Spironolactone may increase the excretion rate of Topiroxostat which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "Spironolactone may increase the excretion rate of Estrone sulfate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04871",
                        "description": "Spironolactone may increase the excretion rate of Lorcaserin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04895",
                        "description": "Spironolactone may increase the excretion rate of Pegaptanib which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04896",
                        "description": "Spironolactone may increase the excretion rate of Milnacipran which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04953",
                        "description": "Spironolactone may increase the excretion rate of Ezogabine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB05018",
                        "description": "Spironolactone may increase the excretion rate of Migalastat which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB05541",
                        "description": "Spironolactone may increase the excretion rate of Brivaracetam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "Spironolactone may increase the excretion rate of Apremilast which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06154",
                        "description": "Spironolactone may increase the excretion rate of Pentaerythritol tetranitrate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06186",
                        "description": "Spironolactone may increase the excretion rate of Ipilimumab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06196",
                        "description": "Spironolactone may increase the excretion rate of Icatibant which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06203",
                        "description": "Spironolactone may increase the excretion rate of Alogliptin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06209",
                        "description": "Spironolactone may increase the excretion rate of Prasugrel which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06211",
                        "description": "Spironolactone may increase the excretion rate of Doripenem which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06228",
                        "description": "Spironolactone may increase the excretion rate of Rivaroxaban which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06230",
                        "description": "Spironolactone may increase the excretion rate of Nalmefene which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06282",
                        "description": "Spironolactone may increase the excretion rate of Levocetirizine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06335",
                        "description": "Spironolactone may increase the excretion rate of Saxagliptin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06402",
                        "description": "Spironolactone may increase the excretion rate of Telavancin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06623",
                        "description": "Spironolactone may increase the excretion rate of Flupirtine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06637",
                        "description": "Spironolactone may increase the excretion rate of Dalfampridine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06700",
                        "description": "Spironolactone may increase the excretion rate of Desvenlafaxine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06702",
                        "description": "Spironolactone may increase the excretion rate of Fesoterodine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06705",
                        "description": "Spironolactone may increase the excretion rate of Gadofosveset trisodium which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06710",
                        "description": "Spironolactone may increase the excretion rate of Methyltestosterone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06782",
                        "description": "Spironolactone may increase the excretion rate of Dimercaprol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06796",
                        "description": "Spironolactone may increase the excretion rate of Mangafodipir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06800",
                        "description": "Spironolactone may increase the excretion rate of Methylnaltrexone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06809",
                        "description": "Spironolactone may increase the excretion rate of Plerixafor which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "Spironolactone may increase the excretion rate of Pralatrexate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06823",
                        "description": "Spironolactone may increase the excretion rate of Tiopronin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06824",
                        "description": "Spironolactone may increase the excretion rate of Triethylenetetramine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08824",
                        "description": "Spironolactone may increase the excretion rate of Ioflupane I 123 which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08826",
                        "description": "Spironolactone may increase the excretion rate of Deferiprone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08840",
                        "description": "Spironolactone may increase the excretion rate of N methylnicotinamide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08872",
                        "description": "Spironolactone may increase the excretion rate of Gabapentin enacarbil which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "Spironolactone may increase the excretion rate of Ruxolitinib which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "Spironolactone may increase the excretion rate of Peginesatide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08897",
                        "description": "Spironolactone may increase the excretion rate of Aclidinium which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08900",
                        "description": "Spironolactone may increase the excretion rate of Teduglutide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "Spironolactone may increase the excretion rate of Certolizumab pegol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08905",
                        "description": "Spironolactone may increase the excretion rate of Formestane which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08909",
                        "description": "Spironolactone may increase the excretion rate of Glycerol phenylbutyrate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "Spironolactone may increase the excretion rate of Pomalidomide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08911",
                        "description": "Spironolactone may increase the excretion rate of Trametinib which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09050",
                        "description": "Spironolactone may increase the excretion rate of Ceftolozane which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09066",
                        "description": "Spironolactone may increase the excretion rate of Corifollitropin alfa which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "Spironolactone may increase the excretion rate of Tasimelteon which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09075",
                        "description": "Spironolactone may increase the excretion rate of Edoxaban which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09081",
                        "description": "Spironolactone may increase the excretion rate of Idebenone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "Spironolactone may increase the excretion rate of Tixocortol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09103",
                        "description": "Spironolactone may increase the excretion rate of Ancestim which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09106",
                        "description": "Spironolactone may increase the excretion rate of Hydroxyethyl Starch which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09111",
                        "description": "Spironolactone may increase the excretion rate of Pentastarch which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09118",
                        "description": "Spironolactone may increase the excretion rate of Stiripentol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09121",
                        "description": "Spironolactone may increase the excretion rate of Aurothioglucose which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "Spironolactone may increase the excretion rate of Dienogest which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09129",
                        "description": "Spironolactone may increase the excretion rate of Chromic chloride which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09132",
                        "description": "Spironolactone may increase the excretion rate of Gadoteric acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09133",
                        "description": "Spironolactone may increase the excretion rate of Iothalamic acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09134",
                        "description": "Spironolactone may increase the excretion rate of Ioversol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09135",
                        "description": "Spironolactone may increase the excretion rate of Ioxilan which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09136",
                        "description": "Spironolactone may increase the excretion rate of Isosulfan blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09137",
                        "description": "Spironolactone may increase the excretion rate of Technetium Tc 99m mebrofenin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09139",
                        "description": "Spironolactone may increase the excretion rate of Technetium Tc 99m oxidronate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09148",
                        "description": "Spironolactone may increase the excretion rate of Florbetaben 18F which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09149",
                        "description": "Spironolactone may increase the excretion rate of Florbetapir 18F which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09156",
                        "description": "Spironolactone may increase the excretion rate of Iopromide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09163",
                        "description": "Spironolactone may increase the excretion rate of Technetium Tc 99m exametazime which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09165",
                        "description": "Spironolactone may increase the excretion rate of Technetium Tc 99m pyrophosphate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09185",
                        "description": "Spironolactone may increase the excretion rate of Viloxazine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09194",
                        "description": "Spironolactone may increase the excretion rate of Etoperidone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09195",
                        "description": "Spironolactone may increase the excretion rate of Lorpiprazole which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09205",
                        "description": "Spironolactone may increase the excretion rate of Moxisylyte which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09209",
                        "description": "Spironolactone may increase the excretion rate of Pholcodine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09210",
                        "description": "Spironolactone may increase the excretion rate of Piracetam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09223",
                        "description": "Spironolactone may increase the excretion rate of Blonanserin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09224",
                        "description": "Spironolactone may increase the excretion rate of Melperone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09255",
                        "description": "Spironolactone may increase the excretion rate of Dextran which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09257",
                        "description": "Spironolactone may increase the excretion rate of Gimeracil which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09262",
                        "description": "Spironolactone may increase the excretion rate of Imidafenacin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09264",
                        "description": "Spironolactone may increase the excretion rate of Idarucizumab which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09265",
                        "description": "Spironolactone may increase the excretion rate of Lixisenatide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09276",
                        "description": "Spironolactone may increase the excretion rate of Sodium aurothiomalate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09277",
                        "description": "Spironolactone may increase the excretion rate of Choline C 11 which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09301",
                        "description": "Spironolactone may increase the excretion rate of Chondroitin sulfate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09317",
                        "description": "Spironolactone may increase the excretion rate of Synthetic Conjugated Estrogens A which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09318",
                        "description": "Spironolactone may increase the excretion rate of Synthetic Conjugated Estrogens B which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09320",
                        "description": "Spironolactone may increase the excretion rate of Procaine benzylpenicillin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09324",
                        "description": "Spironolactone may increase the excretion rate of Sulbactam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09325",
                        "description": "Spironolactone may increase the excretion rate of Sodium fluoride which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09329",
                        "description": "Spironolactone may increase the excretion rate of Antihemophilic Factor Recombinant PEGylated which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09338",
                        "description": "Spironolactone may increase the excretion rate of Mersalyl which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09344",
                        "description": "Spironolactone may increase the excretion rate of Invert sugar which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09357",
                        "description": "Spironolactone may increase the excretion rate of Dexpanthenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09394",
                        "description": "Spironolactone may increase the excretion rate of Phosphoric acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09395",
                        "description": "Spironolactone may increase the excretion rate of Sodium acetate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09407",
                        "description": "Spironolactone may increase the excretion rate of Magnesium chloride which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09488",
                        "description": "Spironolactone may increase the excretion rate of Acrivastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09496",
                        "description": "Spironolactone may increase the excretion rate of Octinoxate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09502",
                        "description": "Spironolactone may increase the excretion rate of Fludeoxyglucose 18F which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09546",
                        "description": "Spironolactone may increase the excretion rate of Iobenguane sulfate I 123 which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11077",
                        "description": "Spironolactone may increase the excretion rate of Polyethylene glycol 400 which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11102",
                        "description": "Spironolactone may increase the excretion rate of N acetyltyrosine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11114",
                        "description": "Spironolactone may increase the excretion rate of Eucalyptus oil which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11127",
                        "description": "Spironolactone may increase the excretion rate of Selenious acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11135",
                        "description": "Spironolactone may increase the excretion rate of Selenium which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11136",
                        "description": "Spironolactone may increase the excretion rate of Chromium which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11145",
                        "description": "Spironolactone may increase the excretion rate of Oxyquinoline which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11156",
                        "description": "Spironolactone may increase the excretion rate of Pyrantel which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11164",
                        "description": "Spironolactone may increase the excretion rate of Bicisate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11251",
                        "description": "Spironolactone may increase the excretion rate of Tocopherol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11328",
                        "description": "Spironolactone may increase the excretion rate of Tetradecyl hydrogen sulfate ester which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11338",
                        "description": "Spironolactone may increase the excretion rate of Clove oil which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11358",
                        "description": "Spironolactone may increase the excretion rate of Evening primrose oil which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11364",
                        "description": "Spironolactone may increase the excretion rate of Pidotimod which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11367",
                        "description": "Spironolactone may increase the excretion rate of Cefroxadine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11560",
                        "description": "Spironolactone may increase the excretion rate of Lesinurad which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11577",
                        "description": "Spironolactone may increase the excretion rate of Indigotindisulfonic acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11598",
                        "description": "Spironolactone may increase the excretion rate of Antithrombin III human which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11642",
                        "description": "Spironolactone may increase the excretion rate of Pitolisant which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11691",
                        "description": "Spironolactone may increase the excretion rate of Naldemedine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11699",
                        "description": "Spironolactone may increase the excretion rate of Tropisetron which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "Spironolactone may increase the excretion rate of Baricitinib which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11915",
                        "description": "Spironolactone may increase the excretion rate of Valbenazine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11943",
                        "description": "Spironolactone may increase the excretion rate of Delafloxacin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11989",
                        "description": "Spironolactone may increase the excretion rate of Benznidazole which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12007",
                        "description": "Spironolactone may increase the excretion rate of Isoflavone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12107",
                        "description": "Spironolactone may increase the excretion rate of Vaborbactam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12151",
                        "description": "Spironolactone may increase the excretion rate of Brincidofovir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12161",
                        "description": "Spironolactone may increase the excretion rate of Deutetrabenazine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12278",
                        "description": "Spironolactone may increase the excretion rate of Propiverine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12783",
                        "description": "Spironolactone may increase the excretion rate of Benserazide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13025",
                        "description": "Spironolactone may increase the excretion rate of Tiapride which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13145",
                        "description": "Spironolactone may increase the excretion rate of Nedaplatin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13156",
                        "description": "Spironolactone may increase the excretion rate of Inosine pranobex which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13178",
                        "description": "Spironolactone may increase the excretion rate of Inositol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13185",
                        "description": "Spironolactone may increase the excretion rate of Oxabolone cipionate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13191",
                        "description": "Spironolactone may increase the excretion rate of Phosphocreatine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13269",
                        "description": "Spironolactone may increase the excretion rate of Dichlorobenzyl alcohol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "Spironolactone may increase the excretion rate of Ipecac which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13595",
                        "description": "Spironolactone may increase the excretion rate of Almasilate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "Spironolactone may increase the excretion rate of Fenofibric acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13884",
                        "description": "Spironolactone may increase the excretion rate of Albutrepenonacog alfa which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13909",
                        "description": "Spironolactone may increase the excretion rate of Bismuth subgallate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13967",
                        "description": "Spironolactone may increase the excretion rate of Patent Blue which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14006",
                        "description": "Spironolactone may increase the excretion rate of Choline salicylate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14007",
                        "description": "Spironolactone may increase the excretion rate of Pentetic acid which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "Spironolactone may increase the excretion rate of Tenofovir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14526",
                        "description": "Spironolactone may increase the excretion rate of Chromic citrate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14527",
                        "description": "Spironolactone may increase the excretion rate of Chromic nitrate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14528",
                        "description": "Spironolactone may increase the excretion rate of Chromium gluconate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14529",
                        "description": "Spironolactone may increase the excretion rate of Chromium nicotinate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14530",
                        "description": "Spironolactone may increase the excretion rate of Chromous sulfate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB14754",
                        "description": "Spironolactone may increase the excretion rate of Solriamfetol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01438",
                        "description": "Spironolactone may increase the excretion rate of Phenazopyridine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06815",
                        "description": "Spironolactone may increase the excretion rate of Pyrithione which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11121",
                        "description": "Spironolactone may increase the excretion rate of Chloroxylenol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00231",
                        "description": "Spironolactone may increase the excretion rate of Temazepam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00363",
                        "description": "Spironolactone may increase the excretion rate of Clozapine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00624",
                        "description": "Spironolactone may increase the excretion rate of Testosterone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00829",
                        "description": "Spironolactone may increase the excretion rate of Diazepam which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01183",
                        "description": "Spironolactone may increase the excretion rate of Naloxone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB11085",
                        "description": "Spironolactone may increase the excretion rate of Resorcinol which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00230",
                        "description": "Spironolactone may increase the excretion rate of Pregabalin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01156",
                        "description": "Spironolactone may increase the excretion rate of Bupropion which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB15593",
                        "description": "Spironolactone may increase the excretion rate of Golodirsen which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00314",
                        "description": "Spironolactone may increase the excretion rate of Capreomycin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00318",
                        "description": "Spironolactone may increase the excretion rate of Codeine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "Spironolactone may increase the excretion rate of Meperidine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00458",
                        "description": "Spironolactone may increase the excretion rate of Imipramine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00512",
                        "description": "Spironolactone may increase the excretion rate of Vancomycin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "Spironolactone may increase the excretion rate of Cisplatin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "Spironolactone may increase the excretion rate of Pemetrexed which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "Spironolactone may increase the excretion rate of Fentanyl which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00879",
                        "description": "Spironolactone may increase the excretion rate of Emtricitabine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00982",
                        "description": "Spironolactone may increase the excretion rate of Isotretinoin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "Spironolactone may increase the excretion rate of Procainamide which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01142",
                        "description": "Spironolactone may increase the excretion rate of Doxepin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01151",
                        "description": "Spironolactone may increase the excretion rate of Desipramine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "Spironolactone may increase the excretion rate of Clomipramine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01267",
                        "description": "Spironolactone may increase the excretion rate of Paliperidone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB06695",
                        "description": "Spironolactone may increase the excretion rate of Dabigatran etexilate which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08934",
                        "description": "Spironolactone may increase the excretion rate of Sofosbuvir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB08996",
                        "description": "Spironolactone may increase the excretion rate of Dimetacrine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09027",
                        "description": "Spironolactone may increase the excretion rate of Ledipasvir which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB12615",
                        "description": "Spironolactone may increase the excretion rate of Plazomicin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "Spironolactone may increase the excretion rate of Carbamazepine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "Spironolactone may increase the excretion rate of Ixazomib which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB13987",
                        "description": "Spironolactone may increase the excretion rate of Strontium chloride which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04890",
                        "description": "Spironolactone may increase the excretion rate of Bepotastine which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "Spironolactone may increase the excretion rate of Warfarin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB01356",
                        "description": "Spironolactone may increase the excretion rate of Lithium cation which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB04930",
                        "description": "Spironolactone may increase the excretion rate of Permethrin which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "Spironolactone may increase the excretion rate of Difluocortolone which could result in a lower serum level and potentially a reduction in efficacy"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The metabolism of Phenprocoumon can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The metabolism of Amiodarone can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The metabolism of Fosphenytoin can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Sorafenib can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Erlotinib can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "The metabolism of Fluorouracil can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The metabolism of Pazopanib can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The metabolism of Cabazitaxel can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The metabolism of Dabrafenib can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB09256",
                        "description": "The metabolism of Tegafur can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12267",
                        "description": "The metabolism of Brigatinib can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Enasidenib can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The metabolism of Phenytoin can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The metabolism of Paclitaxel can be decreased when combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Theodrenaline is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13917",
                        "description": "The risk or severity of Cardiac Arrhythmia can be increased when Deoxyepinephrine is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Tramadol"
                    },
                    {
                        "drugbank-id": "DB00327",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Hydromorphone"
                    },
                    {
                        "drugbank-id": "DB00497",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Oxycodone"
                    },
                    {
                        "drugbank-id": "DB00611",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Butorphanol"
                    },
                    {
                        "drugbank-id": "DB00647",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Dextropropoxyphene"
                    },
                    {
                        "drugbank-id": "DB00652",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Pentazocine"
                    },
                    {
                        "drugbank-id": "DB00704",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00708",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Sufentanil"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Alfentanil"
                    },
                    {
                        "drugbank-id": "DB00844",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Nalbuphine"
                    },
                    {
                        "drugbank-id": "DB00854",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Levorphanol"
                    },
                    {
                        "drugbank-id": "DB00899",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Remifentanil"
                    },
                    {
                        "drugbank-id": "DB00956",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Hydrocodone"
                    },
                    {
                        "drugbank-id": "DB01081",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Diphenoxylate"
                    },
                    {
                        "drugbank-id": "DB01192",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Oxymorphone"
                    },
                    {
                        "drugbank-id": "DB01209",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Dezocine"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Levacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01433",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Methadyl acetate"
                    },
                    {
                        "drugbank-id": "DB01450",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Dihydroetorphine"
                    },
                    {
                        "drugbank-id": "DB01452",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Diamorphine"
                    },
                    {
                        "drugbank-id": "DB01459",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Bezitramide"
                    },
                    {
                        "drugbank-id": "DB01466",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Ethylmorphine"
                    },
                    {
                        "drugbank-id": "DB01497",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Etorphine"
                    },
                    {
                        "drugbank-id": "DB01529",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Dextromoramide"
                    },
                    {
                        "drugbank-id": "DB01531",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Desomorphine"
                    },
                    {
                        "drugbank-id": "DB01535",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Carfentanil"
                    },
                    {
                        "drugbank-id": "DB01551",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Dihydrocodeine"
                    },
                    {
                        "drugbank-id": "DB01555",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Alphacetylmethadol"
                    },
                    {
                        "drugbank-id": "DB01565",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Dihydromorphine"
                    },
                    {
                        "drugbank-id": "DB06204",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Tapentadol"
                    },
                    {
                        "drugbank-id": "DB08861",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with DPDPE"
                    },
                    {
                        "drugbank-id": "DB09174",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Lofentanil"
                    },
                    {
                        "drugbank-id": "DB09272",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Eluxadoline"
                    },
                    {
                        "drugbank-id": "DB11130",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Opium"
                    },
                    {
                        "drugbank-id": "DB11609",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Normethadone"
                    },
                    {
                        "drugbank-id": "DB12492",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Piritramide"
                    },
                    {
                        "drugbank-id": "DB13160",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Alphaprodine"
                    },
                    {
                        "drugbank-id": "DB13454",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Nicomorphine"
                    },
                    {
                        "drugbank-id": "DB13478",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Meptazinol"
                    },
                    {
                        "drugbank-id": "DB13605",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Phenoperidine"
                    },
                    {
                        "drugbank-id": "DB13606",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Phenazocine"
                    },
                    {
                        "drugbank-id": "DB13787",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Tilidine"
                    },
                    {
                        "drugbank-id": "DB15360",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Carfentanil C 11"
                    },
                    {
                        "drugbank-id": "DB15465",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Benzhydrocodone"
                    },
                    {
                        "drugbank-id": "DB00212",
                        "description": "Spironolactone may increase the hypotensive activities of Remikiren"
                    },
                    {
                        "drugbank-id": "DB00226",
                        "description": "Spironolactone may increase the hypotensive activities of Guanadrel"
                    },
                    {
                        "drugbank-id": "DB00374",
                        "description": "Spironolactone may increase the hypotensive activities of Treprostinil"
                    },
                    {
                        "drugbank-id": "DB00606",
                        "description": "Spironolactone may increase the hypotensive activities of Cyclothiazide"
                    },
                    {
                        "drugbank-id": "DB00616",
                        "description": "Spironolactone may increase the hypotensive activities of Candoxatril"
                    },
                    {
                        "drugbank-id": "DB00765",
                        "description": "Spironolactone may increase the hypotensive activities of Metyrosine"
                    },
                    {
                        "drugbank-id": "DB00785",
                        "description": "Spironolactone may increase the hypotensive activities of Cryptenamine"
                    },
                    {
                        "drugbank-id": "DB01021",
                        "description": "Spironolactone may increase the hypotensive activities of Trichlormethiazide"
                    },
                    {
                        "drugbank-id": "DB01089",
                        "description": "Spironolactone may increase the hypotensive activities of Deserpidine"
                    },
                    {
                        "drugbank-id": "DB01090",
                        "description": "Spironolactone may increase the hypotensive activities of Pentolinium"
                    },
                    {
                        "drugbank-id": "DB01116",
                        "description": "Spironolactone may increase the hypotensive activities of Trimethaphan"
                    },
                    {
                        "drugbank-id": "DB01324",
                        "description": "Spironolactone may increase the hypotensive activities of Polythiazide"
                    },
                    {
                        "drugbank-id": "DB03322",
                        "description": "Spironolactone may increase the hypotensive activities of Dexpropranolol"
                    },
                    {
                        "drugbank-id": "DB04831",
                        "description": "Spironolactone may increase the hypotensive activities of Tienilic acid"
                    },
                    {
                        "drugbank-id": "DB04840",
                        "description": "Spironolactone may increase the hypotensive activities of Debrisoquine"
                    },
                    {
                        "drugbank-id": "DB06268",
                        "description": "Spironolactone may increase the hypotensive activities of Sitaxentan"
                    },
                    {
                        "drugbank-id": "DB06403",
                        "description": "Spironolactone may increase the hypotensive activities of Ambrisentan"
                    },
                    {
                        "drugbank-id": "DB06445",
                        "description": "Spironolactone may increase the hypotensive activities of Diethylnorspermine"
                    },
                    {
                        "drugbank-id": "DB06762",
                        "description": "Spironolactone may increase the hypotensive activities of Pinacidil"
                    },
                    {
                        "drugbank-id": "DB07767",
                        "description": "Spironolactone may increase the hypotensive activities of Ferulic acid"
                    },
                    {
                        "drugbank-id": "DB08960",
                        "description": "Spironolactone may increase the hypotensive activities of Hexamethonium"
                    },
                    {
                        "drugbank-id": "DB09206",
                        "description": "Spironolactone may increase the hypotensive activities of Trimazosin"
                    },
                    {
                        "drugbank-id": "DB09363",
                        "description": "Spironolactone may increase the hypotensive activities of Rauwolfia serpentina root"
                    },
                    {
                        "drugbank-id": "DB11720",
                        "description": "Spironolactone may increase the hypotensive activities of Angiotensin 1 7"
                    },
                    {
                        "drugbank-id": "DB12054",
                        "description": "Spironolactone may increase the hypotensive activities of BQ 123"
                    },
                    {
                        "drugbank-id": "DB12465",
                        "description": "Spironolactone may increase the hypotensive activities of Ketanserin"
                    },
                    {
                        "drugbank-id": "DB12661",
                        "description": "Spironolactone may increase the hypotensive activities of Urapidil"
                    },
                    {
                        "drugbank-id": "DB12766",
                        "description": "Spironolactone may increase the hypotensive activities of Cicletanine"
                    },
                    {
                        "drugbank-id": "DB12945",
                        "description": "Spironolactone may increase the hypotensive activities of Dihydralazine"
                    },
                    {
                        "drugbank-id": "DB13211",
                        "description": "Spironolactone may increase the hypotensive activities of Guanoxan"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "Spironolactone may increase the hypotensive activities of Vincamine"
                    },
                    {
                        "drugbank-id": "DB13400",
                        "description": "Spironolactone may increase the hypotensive activities of Linsidomine"
                    },
                    {
                        "drugbank-id": "DB13410",
                        "description": "Spironolactone may increase the hypotensive activities of Guanoxabenz"
                    },
                    {
                        "drugbank-id": "DB13429",
                        "description": "Spironolactone may increase the hypotensive activities of Tolonidine"
                    },
                    {
                        "drugbank-id": "DB13435",
                        "description": "Spironolactone may increase the hypotensive activities of Endralazine"
                    },
                    {
                        "drugbank-id": "DB13452",
                        "description": "Spironolactone may increase the hypotensive activities of Cadralazine"
                    },
                    {
                        "drugbank-id": "DB13532",
                        "description": "Spironolactone may increase the hypotensive activities of Cyclopenthiazide"
                    },
                    {
                        "drugbank-id": "DB13575",
                        "description": "Spironolactone may increase the hypotensive activities of Bietaserpine"
                    },
                    {
                        "drugbank-id": "DB13604",
                        "description": "Spironolactone may increase the hypotensive activities of Guanazodine"
                    },
                    {
                        "drugbank-id": "DB13631",
                        "description": "Spironolactone may increase the hypotensive activities of Methoserpidine"
                    },
                    {
                        "drugbank-id": "DB13779",
                        "description": "Spironolactone may increase the hypotensive activities of Guanoclor"
                    },
                    {
                        "drugbank-id": "DB13801",
                        "description": "Spironolactone may increase the hypotensive activities of Muzolimine"
                    },
                    {
                        "drugbank-id": "DB13803",
                        "description": "Spironolactone may increase the hypotensive activities of Xipamide"
                    },
                    {
                        "drugbank-id": "DB14094",
                        "description": "Spironolactone may increase the hypotensive activities of Tocopherylquinone"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "Spironolactone may increase the hypotensive activities of Levamlodipine"
                    },
                    {
                        "drugbank-id": "DB00945",
                        "description": "Acetylsalicylic acid may decrease the excretion rate of Spironolactone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14507",
                        "description": "The serum concentration of Lithium citrate can be increased when it is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB14509",
                        "description": "The serum concentration of Lithium carbonate can be increased when it is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB14506",
                        "description": "The serum concentration of Lithium hydroxide can be increased when it is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The serum concentration of Digoxin can be increased when it is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "The serum concentration of Metildigoxin can be increased when it is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The serum concentration of Acetyldigoxin can be increased when it is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The risk or severity of hyperkalemia can be increased when Spironolactone is combined with Drospirenone"
                    },
                    {
                        "drugbank-id": "DB14500",
                        "description": "The risk or severity of hyperkalemia can be increased when Potassium is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00814",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Meloxicam"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be increased when it is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06283",
                        "description": "The risk or severity of CNS depression can be increased when Spironolactone is combined with Ziconotide"
                    },
                    {
                        "drugbank-id": "DB09038",
                        "description": "Empagliflozin may increase the diuretic activities of Spironolactone"
                    },
                    {
                        "drugbank-id": "DB14881",
                        "description": "The therapeutic efficacy of Spironolactone can be decreased when used in combination with Oliceridine"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The risk or severity of hypotension can be increased when Sildenafil is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The risk or severity of hypotension can be increased when Vardenafil is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB05266",
                        "description": "The risk or severity of hypotension can be increased when Ibudilast is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06237",
                        "description": "The risk or severity of hypotension can be increased when Avanafil is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB06267",
                        "description": "The risk or severity of hypotension can be increased when Udenafil is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB11792",
                        "description": "The risk or severity of hypotension can be increased when Mirodenafil is combined with Spironolactone"
                    },
                    {
                        "drugbank-id": "DB12010",
                        "description": "The risk or severity of hypotension can be increased when Fostamatinib is combined with Spironolactone"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}